On September 8, 2021 SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, reported that the Company will participate in the following virtual investor conferences in September (Press release, Scynexis, SEP 8, 2021, View Source [SID1234587423]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Presentation details can be found below:
H.C. Wainwright 23rd Annual Global Investment Conference
Format: On demand presentation and 1-on-1 meetings
Date and Time: Presentation available Monday, September 13 at 7 am ET, 1-on-1 meetings September 13-15
Registration Link
Cantor Fitzgerald Virtual Global Healthcare Conference
Format: Live presentation and 1-on-1 meetings
Date and Time: Thursday, September 30 from 2:40-3:10 pm ET (Track 2)
The presentations and archived webcasts can be found on the SCYNEXIS website at: View Source for 30 days following the event.